Identification and characterization of potential new therapeutic targets in inflammatory and autoimmune diseases

European Journal of Biochemistry

Volumn 266, Issue 3, 1999, Pages 1184-1191

  Mangold, Ursula ^a   Dax, Claudia I ^b   Saar, Karin ^c   Schwab, Wilfried ^a   Kirschbaum, Bernhard ^a   Müllner, Stefan ^d  

^a SANOFI   (France)

^b BASF SE   (Germany)

^c SANOFI AVENTIS DEUTSCHLAND GMBH   (Germany)

^d HENKEL KGAA   (Germany)

Author keywords

Affinity chromatography; BIAcore ; Immune system; Leflunomide; Mode of action

Indexed keywords

ANTIINFLAMMATORY AGENT; DIHYDROOROTATE DEHYDROGENASE; DRUG BINDING PROTEIN; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; LEFLUNOMIDE; PHOSPHOGLYCERATE MUTASE; PYRUVATE KINASE;

AFFINITY CHROMATOGRAPHY; AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; CYTOSOL; DRUG PROTEIN BINDING; DRUG TARGETING; GLYCOLYSIS; HELA CELL; HUMAN; HUMAN CELL; IMMUNOREGULATION; INFLAMMATION; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PURIFICATION;

AMINO ACID SEQUENCE; ANILINE COMPOUNDS; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CARRIER PROTEINS; CELL LINE; CHROMATOGRAPHY, AFFINITY; HELA CELLS; HUMANS; HYDROXYBUTYRATES; IMMUNOSUPPRESSIVE AGENTS; ISOXAZOLES; KINETICS; MICE; MOLECULAR SEQUENCE DATA; PROTEIN BINDING;

EID: 0033573158     PISSN: 00142956     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1432-1327.1999.00978.x     Document Type: Article

References (27)

1. 1. Bartlett, R.R., Dimitrijevic, M., Mattar, T., Zielinski, T., Germann, T., Ruede, E., Thoenes, G.H., Küchle, C.C.A., Schorlemmer, H.-U., Bremer, E., Finnegan, A. & Schleyerbach, R. (1991) Leflunomide (HWA 486), a novel immunomodulating compound for the treatment of autoimmune disorders and reactions leading to transplantation rejection. Agents Actions 31 (1/2), 10-21.
2. 2. Kuchle, C.C., Thoenes, G.H., Langer, K.H., Schorlemmer, H.U., Bartlett, R.R. & Schleyerbach, R. (1991) Prevention of kidney and skin graft rejection in rats by leflunomide, a new immunomodulating agent. Transplant. Proc. 23, 1083-1086.
3. 3. Smolen, J.S., Kalden, J.R., Scott, D.L., Rozman, B., Kvien, T.K., Larsen, A., Loew-Friedrich, I., Oed, C., Rosenburg, R. & the European Leflunomide Study Group (1999) Efficacy and safety of leflunomide compared with placebo and sulphasalazine in active rheumatoid arthritis: a double-blind randomised, multicentre trial. Lancet 353, 259-266.
4. 4. Schreiber, S.L. & Crabtree, G.R. (1992) The mechanism of action of cylosporin A and FK506. Immunol. Today 13, 136-142.
5. 5. Williamson, R.A., Yea, C.M., Robson, P.A., Curnock, A.P., Gadher, S., Hambleton, A.B., Woodward, K., Bruneau, J.-M., Hambleton, P., Moss, D., Thomson, T.A., Spinella-Jaegle, S., Morand, T., Courtin, O., Sautés, C., Westwood, R., Hercend, T., Kuo, E.A. & Ruuth, E. (1995) Dihydroorotate dehydrogenase is a high affinity binding protein of A 77, 1726 and mediator of a range of biological effects of the immunomodulatory compound. J. Biol. Chem. 270, 22467-22472.
6. 6. Knecht, W., Bergjohann, U., Gonski, S., Kirschbaum, B. & Loeffler, M. (1996) Functional expression of a fragment of human dihydroorotate dehydrogenase by means of the baculovirus expression vector system, and kinetic investigation of the purified recombinant enzyme. Eur. J. Biochem. 240, 292-301.
7. 7. Fairbanks, L.D., Bofill, M., Ruckemann, K. & Simmonds, H.A. (1995) Importance of ribonucleotide availability to proliferating T-Lymphocytes from healthy humans. J. Biol. Chem. 270, 29682-29689.
8. 8. Xu, X., Williams, J.W., Bremer, E.G., Finnegan, A. & Chong, A.S.F. (1995) Inhibition of protein tyrosine phosphorylation in T cells by a novel immunosuppressive agent, leflunomide. J. Biol. Chem. 270, 12398-12403.
9. 9. Müllner, S., Kirschbaum, B. & Schwab, W. (1998) Isoxazol amide and crotonamide derivatives and their use as drugs and diagnostics. German Patent Application, Offenlegungsschrift DE 19702988.
10. 10. Müller, E., Mack, M. & Britsch, L. (1994) Separating Materials and Process for their Preparation. PCT Patent Application, PCT/EP95/ 04217 (WO 96/14151).
11. 11. Dax, C.I. (1996) Proteinchemische Methoden zur Identifizierung und Charakterisierung entzündungsrelevanter Polypeptide. PhD Thesis, University of Frankfurt, Frankfurt/Main, Germany.
12. 12. Laemmli, U.K. (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680-685.
13. 13. Heukeshoven, J. & Dernick, R. (1985) Simplified method for silver staining of proteins in polyacrylamide gels and the mechanism of silver staining. Elektrophoresis 6, 103-112.
14. 14. Sherry, B., Yarlett, N., Strupp, A. & Cerami, A. (1992). Identification of cyclophilin as a proinflammatory secretory product of lipopolysaccharide-activated macrophages. Proc. Natl Acad. Sci. USA 89, 3511-3515.
15. 15. Cronstein, B.N., Bouma, M.G. & Becker, B.F. (1997) Purinergic mechanisms in inflammation. Drug Dev. Res. 39, 426-435.
16. 16. Glauser, Michel, P. (1996) The inflammatory cytokines. New developments in the pathophysiology and treatment of septic shock. The inflammatory cytokines. New developments in the pathophysiology and treatment of septic shock. Drugs 52 (Suppl. 2), 9-17.
17. 17. Nicod, L.P., Galve-De-Rochemonteix, B. & Dayer, J.M. (1994) Modulation of IL-1 receptor antagonist and TNF-soluble receptors produced by alveolar macrophages and blood monocytes. Ann. N.Y. Acad. Sci. 725, 323-330.
18. 18. Eigenbrodt, E., Gerbracht, U., Mazurek, S., Presek, P. & Friis, R. (1994). Carbohydrate metabolism and neoplasia: new perspectives for diagnosis and therapy. Biochem. Mol. Aspects Selected Cancers 2, 311-385.
19. 19. Méjean, C., Pons, F., Benyamin, Y. & Roustan, C. (1989) Antigenic probes locate binding sites for the glycolytic enzymes glyceralehyde-3-phosphate dehydrogenase, aldolase and phosphofructokinase on the actin monomer in microfilaments. Biochem. J. 264, 671-677.
20. 20. Wu, Y.W., Chik, C.L. & Knazek, R.A. (1989) An in vitro and in vivo study of antitumor effects of gossypol on human SW-13 adrenocortical carcinoma. Cancer Res. 49, 3754-3758.
21. 21. Lindquist, S. (1986) The heat shock response. Annu. Rev. Biochem. 55, 1151.
22. 22. Craig, E.A. (1993) Chaperones: helpers along the pathways to protein folding. Science 260, 1902-1903.
23. 23. Winfield, J. & Jarjour, W. (1991) Do stress proteins play a role in arthritis and autoimmunity? Immunol. Rev. 121, 121-220.
24. 24. Ishii, T., Yamada, M., Sato, H., Matsue, M., Taketani, S., Nakayama, K., Sugita, Y. & Bannai, S. (1993) Cloning and characterization of a 23-kDa stress-induced mouse peritoneal macrophage protein. J. Biol. Chem. 268, 18633-18636.
25. 25. Kawai, S., Takeshita, S., Okazaki, M., Kikuno, R., Kudo, A. & Amann, E. (1994) Cloning and characterization of OSF-3, a new member of the MER5 family, expressed in mouse osteoplasmatic cells. J. Biochem. 115, 641-643.
26. 26. Shau, H., Butterfield, L.H., Chiu, R. & Kim, A. (1994) Cloning and sequence analysis of candidate human natural killer-enhancing factor genes. Immunogenetics 40, 129-134.
27. 27. Wen, S.-T. & Van Etten, R.A. (1997) The PAG gene product, a stress-induced protein with antioxidant properties, is an Ab1 SH3-binding protein and a physiological inhibitor of c-Ab1 tyrosine kinase activity. Genes Dev. 11, 2456-2467.